First Choice Healthcare Solutions, Inc. FCHS

FY2013 · ended Dec 31, 2013 · Revenue $1.05M, -9.6% YoY · Filed Apr 15, 2015

First Choice Healthcare Solutions, Inc. (FCHS) files with the SEC under industry code 8071, Services-Medical Laboratories. As of Jun 30, 2026 it held $6,842 in cash and investments and $3.3 million in total debt.

Revenue (TTM)
$1.05M
-1.6% vs year-ago TTM
Net income (TTM)
$-5.00M
-496.9% vs year-ago TTM
Operating cash flow (TTM)
$-485,788
+63.2% vs year-ago TTM
Free cash flow
$-6.88M
-92.6% vs prior year
EPS
$-0.21
-75.0% vs prior year
Dividend per share
None
Shares outstanding
32.96M
+0.0% vs prior year
Net cash
$-3.28M
as of Jun 30, 2026
Operating margin
-135.1%
FY 2014

Company profile

Industry
Services-Medical Laboratories (SIC 8071)
Listed as
FCHS (OTC)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Melbourne, FL
SEC filer status
, Emerging growth company
SEC CIK
1416876
Former names
Medical Billing Assistance, Inc. (until Mar 30, 2012); Medical Billing Assistance Inc (until Jan 3, 2011)

Other Services-Medical Laboratories companies

Key figures

Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.

Line
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2017
Dec 31, 2017
FY 2016
Dec 31, 2016
Operating income
-$2.7M
-$1.3M
-$2.4M
-$4.4M
$139,653
Net income
-$7.0M
-$3.8M
-$8.2M
$3.9M
$9.2M
Diluted EPS
-$0.21
-$0.12
-$0.25
-$0.15
$0.37
Operating cash flow
-$549,019
-$1.7M
-$6.8M
—
—
Free cash flow
—
—
-$6.9M
—
—
Total assets
$4.0M
$4.5M
$3.1M
$18.8M
$22.1M
Total liabilities
$43.6M
$37.0M
$31.7M
$7.3M
$7.2M
Stockholders' equity
-$39.5M
-$32.5M
-$28.5M
$11.0M
$13.9M
Cash and investments
$5,896
$19,915
$12,607
$2.0M
$4.6M
Total debt
$3.3M
$3.6M
$2.7M
$2.7M
$2.4M

Recent SEC filings

Recent SEC filings
Form Description Filed Period
8-K Current report
Material agreement
Aug 19, 2026 Jul 22, 2026
10-Q Quarterly report Aug 13, 2026 Jun 30, 2026
8-K Current report
Material agreement, Regulation FD disclosure
Jul 28, 2026 Jul 22, 2026
10-Q Quarterly report May 8, 2026 Mar 31, 2026
10-K Annual report Mar 11, 2026 Dec 31, 2025
10-Q Quarterly report Nov 12, 2025 Sep 30, 2025

Source: SEC EDGAR filings. This is company-reported data, not investment advice.